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There are approximately 1000 to 10,000 mitochondria in a human cell. These organelles function to 
provide energy to the cell but encode a genome separate from the nuclear genome. Deletions in the 
mitochondrial genome are associated with several pathogenic conditions and are believed to 
contribute to the aging process. Deletions must be present in the majority of mitochondria in a cell 
before these phenotypes are manifested; however, it is unclear if these deletions arise early and 
accumulate through a process of clonal expansion, or if there is a continual generation and 
accumulation of deletions over time. In a recent report published inAging Cell Drs. Sean D. Taylor 
and Jason H. Bielas (Public Health Sciences and Human Biology) and their collaborators 
demonstrate a sensitive deletion detection assay and provide support for the hypothesis that 
mitochondrial genome deletions arise early and are propagated by clonal expansion. 
Current methods for the detection of deletions in genomes are labor intensive and susceptible to 
various artifacts that reduce their accuracy. PCR-based methods are susceptible to template 
switching or preferential amplification of short amplicons, while Southern blotting or next generation 
sequencing techniques are not sensitive enough to detect early deletion events against the 
background of wildtype genomes. To address these issues, Taylor et al. developed a very sensitive 
three step process known as Digital Deletion Detection to characterize rare deletion events (3D; see 
figure). In this method, samples are first enriched for deleted genomes by endonucleolytic digestion. 
This step destroys wildtype templates but spares templates with deletions that remove these 
endonuclease recognition sequences. These enriched templates are then subjected to single 
molecule droplet PCR scaled so that each droplet contains either no template or at most a single 
genome. This single molecule amplification prevents many PCR artifacts such as template switching 
to bias amplification. Finally, the deletions are either quantified by droplet digital PCR, which directly 
counts droplets containing an amplified template, and therefore a deletion, or the reactions are 
subjected to next generation sequencing to characterize unique deletions. Using 3D methodology, 
Taylor et al. were able to detect deletions as rare as 1 event in 100 million genomes, and deletion 
detection was accurate over 8 orders of magnitude. Furthermore, the mean fluorescence intensity of 
droplets was inversely proportional to the size of the amplicon (smaller amplicons were brighter), 
allowing the researchers to determine whether samples had a single deletion or a complex mixture 
of deletions by flow cytometry of the droplets. 
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Taylor, et al. used this 3D technique to characterize the deletion dynamics of two sites in the 
mitochondrial genome.  Both deletions increased in frequency with respect to the age of the patient; 
the “common deletion” increased over 300-fold between samples of 15-year-olds and 80-year-olds, 
while a deletion at the ND1/ND2 site increased approximately 25-fold. Interestingly, the frequency of 
the ND1/ND2 deletion was more strongly correlated with age than the “common deletion” (R2 = 
0.812 vs. 0.453). Finally, Taylor, et al. subjected the amplification products to deep sequencing to 
determine whether the deletions were clonal or heterogeneous.  They found that the “common 
deletion” site was generally dominated by a single deletion while there was a heterogeneous 
distribution of deletion sizes at the ND1/ND2 site. However, even at the ND1/ND2 site most of the 
deletion load was dominated by a few discrete deletions representing 1 to 10% of the total deletion 
burden individually. Taken together, these data support the hypothesis that mitochondrial genome 
deletions arise early and are propagated by clonal expansion or preferential replication. 
Mitochondria are key organelles in cellular metabolism, but the maintenance of their genomes is 
poorly understood. With the sensitive new Digital Deletion Detection assay, it is now possible to 
identify the origin of deletions in the mitochondrial genome and define how they accumulate over 
time. "The same principles used for the detection of rare deletion events also apply to the detection 
of rare nuclear variants or the detection of disease biomarkers," said Dr. Taylor, making 3D 
technology a powerful new tool to investigate genetic changes in both normal and disease states. 
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Image courtesy Dr. Sean D. Taylor 
Schematic of the Digital Deletion Detection protocol. Samples are 1) enriched by 
endonucleoyltic digestion, 2) amplified by digital droplet PCR, then 3) characterized by a 
variety of methods. 
 
